UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fatty acid-related modulations of membrane fluidity in cells: detection and implications

Free radical research, 2016-11, Vol.50 (sup1), p.S40-S50

2016

Volltextzugriff (PDF)

Unprecedented Leadership: Learning to Lead in Turbulent Times

1, 2022

Volltextzugriff (PDF)

Modeling of anaerobic digestion of slaughterhouse wastes after thermal treatment using ADM1

Journal of environmental management, 2018-10, Vol.224, p.49-57

2018

Volltextzugriff (PDF)

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

Leukemia, 2012-06, Vol.26 (6), p.1211-1217

2012

Volltextzugriff (PDF)

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

Clinical microbiology and infection, 2014-01, Vol.20 (1), p.O50-O57

2014

Volltextzugriff (PDF)

Dose individualization of intravenous busulfan in pediatric patients undergoing bone marrow transplantation: impact and in vitro evaluation of infusion lag-time

Journal of pharmacy and pharmacology, 2021-10, Vol.73 (10), p.1340-1350

2021

Volltextzugriff (PDF)

Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis

European review for medical and pharmacological sciences, 2022-10, Vol.26 (20), p.7705

2022

Volltextzugriff (PDF)

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2016-10, Vol.51 (10), p.1313-1317

2016

Volltextzugriff (PDF)

Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia

Bone marrow transplantation (Basingstoke), 2017-03, Vol.52 (3), p.445-451

2017

Volltextzugriff (PDF)

HLA-G 14-bp polymorphism affects the age of onset in Type I Diabetes Mellitus

International journal of immunogenetics, 2016-06, Vol.43 (3), p.135-142

2016

Volltextzugriff (PDF)

P529: FIRST EUROPEAN REAL‐WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST‐LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST‐IN‐CLASS CD123‐TARGETED THERAPY TAGRAXOFUSP

HemaSphere, 2022-06, Vol.6, p.428-429

2022

Volltextzugriff (PDF)

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1363-1368

2011

Volltextzugriff (PDF)

CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia

Bone marrow transplantation (Basingstoke), 2012-03, Vol.47 (3), p.411-415

2012

Volltextzugriff (PDF)

Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites

Haematologica (Roma), 2012-09, Vol.97 (9), p.1338-1347

2012

Volltextzugriff (PDF)

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients

Bone marrow transplantation (Basingstoke), 2007-05, Vol.39 (10), p.613-622

2007

Volltextzugriff (PDF)

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia

Leukemia, 2010-03, Vol.24 (3), p.536-543

2010

Volltextzugriff (PDF)

Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes

Bone marrow transplantation (Basingstoke), 2014-08, Vol.49 (8), p.1022-1028

2014

Volltextzugriff (PDF)

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

Leukemia, 2005-05, Vol.19 (5), p.814-821

2005

Volltextzugriff (PDF)

Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives

Bone marrow transplantation (Basingstoke), 2004-12, Vol.34 (11), p.923-928

2004

Volltextzugriff (PDF)

c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia

Leukemia, 2008-10, Vol.22 (10), p.1899-1908

2008

Volltextzugriff (PDF)

Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease

Bone marrow transplantation (Basingstoke), 2011-08, Vol.46 (8), p.1161-1162

2011

Volltextzugriff (PDF)

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

Haematologica (Roma), 2020-01, Vol.105 (1), p.47-58

2020

Volltextzugriff (PDF)

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

Bone marrow transplantation (Basingstoke), 2008-05, Vol.41 (10), p.845-850

2008

Volltextzugriff (PDF)

Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALL

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (12), p.829-831

2008

Volltextzugriff (PDF)

1 – 25 von 397

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(353)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Fatty acid-related modulations of membrane fluidity in cells: detection and implications

Unprecedented Leadership: Learning to Lead in Turbulent Times

Modeling of anaerobic digestion of slaughterhouse wastes after thermal treatment using ADM1

Comparative study of treosulfan plus Fludarabine (FT14) with busulfan plus Fludarabine (FB4) for acute myeloid leukemia in first or second complete remission: An analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)

Outcomes and prognostic factors of adults with acute lymphoblastic leukemia who relapse after allogeneic hematopoietic cell transplantation. An analysis on behalf of the Acute Leukemia Working Party of EBMT

A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies

Dose individualization of intravenous busulfan in pediatric patients undergoing bone marrow transplantation: impact and in vitro evaluation of infusion lag-time

Clinical outcomes in vaccinated and unvaccinated patients with COVID-19: a population-based analysis

Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation

Low-dose alemtuzumab for GvHD prevention followed by prophylactic donor lymphocyte infusions in high-risk leukemia

HLA-G 14-bp polymorphism affects the age of onset in Type I Diabetes Mellitus

P529: FIRST EUROPEAN REAL‐WORLD EVIDENCE PROSPECTIVE REGISTRY OF FIRST‐LINE ADULT PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM TREATED WITH FIRST‐IN‐CLASS CD123‐TARGETED THERAPY TAGRAXOFUSP

Pharmacokinetics and clinical activity of very low-dose alemtuzumab in transplantation for acute leukemia

CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia

Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites

Lymphocyte reconstitution following allogeneic hematopoietic stem cell transplantation: a retrospective study including 148 patients

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia

Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes

Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation

Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives

c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia

Successful mobilization with plerixafor and autologous hematopoietic SCT in a patient with refractory Hodgkin's lymphoma and Gaucher disease

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the Acute Leukemia Working Party of the EBMT

A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation

Long-term lymphoid-restricted split chimerism after myeloablative allogeneic BMT for bcr-abl+ ALL

Suchergebnisse filtern